Related Experiment Videos
Mutational analysis and genotype/phenotype correlation in Turkish Charcot-Marie-Tooth Type 1 and HNPP patients
N Bissar-Tadmouri1, Y Parman, L Boutrand
1Bogazici University, Department of Molecular Biology and Genetics, Bebek, Istanbul, Turkey.
Clinical Genetics
|January 5, 2001
Summary
Researchers identified novel mutations in PMP22 and Cx32 genes in Turkish patients with Charcot-Marie-Tooth Type 1 (CMT1) and Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). These genetic findings correlate with disease severity.
Area of Science:
- Neurogenetics
- Molecular Biology
- Clinical Neurology
Background:
- Charcot-Marie-Tooth Type 1 (CMT1) and Hereditary Neuropathy with Liability to Pressure Palsies (HNPP) are often linked to genetic alterations in the 17p11.2 region.
- Previous studies identified point mutations in PMP22, MPZ, and Cx32 genes in CMT1 and PMP22 in HNPP patients lacking deletions.
Purpose of the Study:
- To investigate mutations in PMP22 and Cx32 genes in Turkish patients diagnosed with CMT1 and HNPP, specifically those without large deletions or duplications.
- To correlate identified genetic mutations with the clinical presentation and severity of these peripheral neuropathies.
Main Methods:
- Genetic screening of PMP22 and Cx32 genes was performed on DNA samples from 54 CMT1 patients and 25 HNPP patients from Turkey.
- Mutation analysis included sequencing of coding regions and flanking intronic sequences of the target genes.
- Clinical data and phenotypes of the patients were collected and analyzed in conjunction with genetic findings.
Main Results:
- A novel frameshift mutation in the PMP22 gene was identified in an HNPP patient.
- A point mutation in the PMP22 gene was detected in a CMT1 patient.
- Two distinct point mutations in the Cx32 gene were found in two CMTX patients, and a polymorphism was identified in another patient.
Conclusions:
- The study identified novel PMP22 and Cx32 gene mutations in Turkish patients with CMT1 and HNPP, expanding the spectrum of known mutations.
- The identified mutations and polymorphism in PMP22 and Cx32 genes correlate with the clinical phenotypes observed in the patients.
- These findings contribute to a better understanding of the genetic basis of CMT1 and HNPP and emphasize the importance of genetic testing in diagnosis and management.